Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ingo Haller is active.

Publication


Featured researches published by Ingo Haller.


American Journal of Obstetrics and Gynecology | 1985

Mode of action of clotrimazole: implications for therapy.

Ingo Haller

Ergosterol is an essential constituent of the fungal cytoplasmic membrane. Clotrimazole and other azoles interfere with the ergosterol biosynthesis in a concentration-dependent fashion. Although low concentrations exhibit only a partially inhibitory effect, high concentrations may completely block ergosterol synthesis. Reduction of fungal growth and inhibition of growth and fungicidal action during prolonged incubation are the corresponding effects at the cellular level that are a consequence of ergosterol depletion. The inoculum effect, the influence of the incubation period, and the influence of nutrient media, three factors that often complicate susceptibility testing in vitro, can also be explained by the mode of action of azole compounds. Another interesting characteristic of azole antifungals was revealed by the observation that hyphae and pseudomycelia of Candida albicans are much more susceptible to azoles than are yeast cells. Even 1% of the minimum inhibitory concentration of clotrimazole may totally inhibit mycelial growth in vitro. This may be of clinical importance, since germination was reported to enhance adherence of C. albicans to buccal and vaginal epithelial cells.


Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie | 1982

Zur Resistenzlage von Staphylococcus aureus: β-Laktamasebildung und Empfindlichkeit gegenüber verschiedenen penicillinen sowie erythromycin

Ingo Haller; Siegfried Heinrich

Abstract The actual resistance of Staphylococcus aureus from different clinics in Bielefeld was examined on the basis of 155 strains freshly isolated from clinical specimens during a period of two months. Sensitivity of these strains was assessed by minimum inhibitory concentrations (MICs) as determined by agar dilution method. As expected oxacillin proved to be the most effective compound according to its stability to β-lactamases. Ampicillin and amoxicillin were nearly as active as penicillin G, while propicillin exhibited a higher activity than penicillin G against those strains which were moderately sensitive to penicillin G. MICs of erythromycin were similar to those of propicillin and most of the highly penicillin resistant strains proved to be resistant to erythromycin too. When comparing the acylureidopenicillins and ticarcillin nearly identical MIC values resulted for azlocillin, mezlocillin and piperacillin; ticarcillin was found to be slightly less active. The qualitative assay for β-lactamase activity performed after induction with methicillin demonstrated strong correlation between presence or absence of β-lactamases and sensitivity of the bacteria to penicillin G. β-lactamase activity could be found in almost all strains with MIC ≧ 0.25 μg/ml for penicillin G. These results are discussed with respect to the recommendations for susceptibility testing.


Archive | 1995

7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives

Uwe Petersen; Thomas Schenke; Andreas Krebs; Klaus Grohe; Michael Schriewer; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1992

Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents

Uwe Petersen; Andreas Krebs; Thomas Schenke; Thomas Philipps; Klaus Grohe; Klaus-Dieter Bremm; Rainer Endermann; Karl-Georg Dr Metzger; Ingo Haller


Archive | 1989

7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridone-carboxylic-acid derivatives, method for their preparation and for substituted mono- and bi-cyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions

Uwe Petersen; Thomas Schenke; Andreas Krebs; Klaus Grohe; Michael Schriewer; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1990

7-(4-OXA OR 4-THIA-2,7-DIAZABICYCLO(3.3.0)OCT-2-EN-3-YL)-3-QUINOLONE-AND-NAPHTHYRIDONE-CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS AND FEED ADDITIVES

Uwe Petersen; Thomas Schenke; Andreas Krebs; Klaus Grohe; Michael Schriewer; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1988

5-Substituted quinolone- and naphthyridone carboxylic acid derivatives

Uwe Petersen; Klaus Grohe; Michael Schriewer; Thomas Schenke; Ingo Haller; Karl Dr Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1990

Antibacterial 5-alkylquinolonecarboxylic acids

Michael Schriewer; Klaus Grohe; Andreas Krebs; Uwe Petersen; Thomas Schenke; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1990

5-Alkylquinolinone carboxylic acids

Michael Schriewer; Klaus Grohe; Andreas Krebs; Uwe Petersen; Thomas Schenke; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler


Archive | 1991

7-(1-pyrrolidinyl)-3-quinolone carboxylic acid derivatives as antibacterial agents and feed additives

Uwe Petersen; Thomas Schenke; Andreas Krebs; Klaus Grohe; Michael Schriewer; Ingo Haller; Karl Georg Metzger; Rainer Endermann; Hans-Joachim Zeiler

Researchain Logo
Decentralizing Knowledge